Bulma moved through the product line without wasted motion, each section given the time it needed and no more. The universal capsule update came third — after the combat capability detector and the Baymax v2, both of which had done the work of establishing the audience's baseline expectation for what "upgrade" meant. Against that context, the capsule expansion landed with the specific pleasure of things that solve obvious problems you've been living with so long you stopped noticing them.
More vehicle categories. Watercraft now. Larger aircraft. The product line had grown from a demonstration of possible into a comprehensive transportation infrastructure — everything from a motorcycle to a small passenger plane, all compressible to fifty grams, all retrievable by palm print. The crowd in the hall absorbed this and the crowd watching the stream at home processed the implications for what personal mobility looked like when weight and volume ceased to be constraints.
In the audience, Darren Cross leaned close to Hank and kept his voice down.
"The shrinking mechanism," he said. "Object compression, spatial storage, dimensional recovery — it's not the same as Pym Particles at the fundamental level, but the application set overlaps significantly."
Hank looked at the screen showing a sailboat capsule deploying into a marina. "The physics are different. The design philosophy isn't."
"Which means the market we thought was ours is now contested."
"The market we thought was ours was never actually ours," Hank said. "We were holding a technology we hadn't commercialized. The fact that they got to commercial applications first isn't competition. It's a reminder."
Darren absorbed this without responding to it. He turned back to the stage.
"The first new product," Bulma said, "is a spaceship."
The hall went quiet in the specific way that rooms go quiet when something has been said that crosses a category boundary.
Two vessels appeared on the screen — one small and spherical, clearly a single-occupant craft, the design having the functional directness of something built for efficiency over aesthetics. The second was larger, multi-deck, a design that implied habitation rather than transit.
"We've built two variants," Bulma said. "A single-person craft for solo travel, and a larger vessel for group expeditions. Both use faster-than-light propulsion systems. In practical terms: Earth to Asgard, single-person craft, six days."
The silence held for another second. Then the room recalibrated into noise.
Tony turned to Smith. "You rode one of these before right?"
"Yeah," Smith said.
Ross was writing something on a notepad, his pen moving faster than note-taking required. The Moon had resources. Mars had resources. The asteroid belt had resources that made the Moon and Mars look like opening bids. With transit times measured in days rather than years—
He underlined something twice.
Bulma continued: "For those who want to visit Asgard — we've worked with the Asgardian embassy in New York to establish a visa pathway. The application process will be announced separately." She paused. "And for those who'd prefer not to buy a spacecraft, we'll be offering commercial routes. Lunar tours. Asgard round-trips. Solar system circuits. Booking opens next month."
The customer service lines for Capsule Corporation had been running at high volume since the products were announced a month ago. They went to a different category entirely in the next four minutes.
In orbit, Fury watched the broadcast from the SWORD station's monitor array and thought about everything he'd tried to build during his tenure as SHIELD director — the early warning systems, the helicarrier program, the international partnerships. All of it predicated on the assumption that Earth's first line of defense was Earth. That the frontier was the sky above, and his job was to watch it.
Smith Doyle had just commercialized access to the rest of the solar system. Whatever the frontier was, it had moved again.
"One more new product," Bulma said.
The crowd had been through enough by this point to not assume they knew what was coming.
"Some of you will have encountered this before, through the rumor or through specific SHIELD partnerships. Most people haven't." She brought up the product card. "It's called a wax bath."
The medical terminology she used was precise without being inaccessible — she'd tested the language with three different audience profiles before the presentation. What she described was a treatment system that, for non-fatal injuries, could compress a month's recovery into a single night. Fractures. Lacerations. Penetrating wounds. Gunshot trauma. The injuries that took people off their feet for weeks and put them through rehabilitation cycles and produced lasting impairments — all of it addressed by a treatment that functioned while you slept.
"We're making this available commercially," she said. "Franchise locations, hospital partnerships, direct retail in major markets. Pricing will be accessible."
Coulson wrote something in the margin of his notepad. He'd had access to wax bath technology for months through SHIELD's Fraternity arrangement, and had watched it change what field operations looked like when injured agents didn't stay injured. The commercial rollout meant the technology moved from a SHIELD-adjacent advantage to a general availability product. The advantage narrowed. The benefit to civilians broadened. He thought about which of those things mattered more and concluded that both of them did.
The applause at the end of Bulma's presentation was the sustained kind that means people have genuinely received something they didn't have before.
The hall opened for the company sessions, and over the next several days the stage cycled through presentations from Stark Industries, Pym Technologies, Vanko Industries, and the roster of other participants. The expo format Bulma had chosen meant that Capsule Corporation's opening presentation set a reference point that every subsequent company was measured against, which was not an accident.
On the second morning, Darren Cross took the main stage.
He was good at it — that was the first thing that registered. Poised, practiced, his pace on stage measured and his pauses placed. He thanked the Capsule Corporation for the platform with the right ratio of genuine to strategic.
Smith had come early. He sat in the audience beside Bulma, which had produced a small effect in the rows around them — people noticing, adjusting their attention slightly. Bulma was watching the stage with an interest that was different from how she'd watched the other company presentations.
"Hank Pym is genuinely talented," Smith said. "Especially in the particle work."
"Is this the shrinking technology?" Bulma asked.
"Something in that direction."
On stage, Darren walked through his opening — acknowledging the emergence of the extraordinary as the context for what he was about to present, the way the impossible had become the new baseline for what people expected from science. He brought up Hank Pym's photograph on the screen behind him.
"Our founder," he said. "Dr. Hank Pym."
Hank, in the audience three rows ahead of Smith and Bulma, sat with his arms folded and did not look at the photograph of himself. His expression was the controlled version — not the feeling he was having, but the face he was presenting over it.
"When I was brought into Pym Technologies," Darren continued, "Dr. Pym was working on particle research that he'd never released publicly. He had his reasons." He looked at Hank in the audience. "Dr. Pym, I hope you'll forgive me for what I'm about to show everyone."
Hank's expression didn't change.
The screen showed historical footage — early footage, the quality indicating analog recording, the kind that would have been made in the seventies or early eighties. A figure, the size of an insect by the camera's scale, moving through what appeared to be a battlefield scenario. The figure moved without hesitation, each approach committed to the moment it began. Obstacles that would have stopped a conventional soldier were irrelevant at that scale.
Bulma's head tilted slightly. "That's a person."
"Compressed," Smith said. "The particles alter the distance between atoms. Mass stays constant, volume decreases. So strength scales up relative to size."
"My shrinking bracelet does something similar," Bulma said. "But I was thinking about it as a transport problem, not a combat application."
"That's the difference in approach," Smith said.
On stage, Darren delivered his rhetorical pivot — the legend, the proof, the bridge from history to present. "What was once a single person's technology, developed in secret and kept hidden for reasons that no longer apply—" he paused for the audience's benefit, "—is now a product."
The screen changed.
The suit that appeared was not the Ant-Man suit. It was sleeker, more aggressive in its design language, the helmet architecture suggesting active threat capability rather than the original suit's functional anonymity. It was small enough on the display to be presented through a specialized magnifying lens mounted beside the screen, which gave it the quality of something rare and precise.
"The Yellowjacket," Darren said. "A miniaturization combat platform. Full human-scale strength at insect-scale profile. Undetectable to standard security systems at operational size. The most complete personnel-scale tactical tool developed by anyone on Earth."